Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00376948 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DIETARY_SUPPLEMENT: genistein
DRUG: erlotinib hydrochloride
DRUG: gemcitabine hydrochloride

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]